Ondine Biomedical, Inc.'s total assets for Q2 2022 were C$25.31M, a decrease of -25.86% from the previous quarter. GB:OBI total liabilities were C$3.49M for the fiscal quarter, a -22.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.